Santander

Confirmed guidance

29/10/24 -"The third-quarter results were in line with expectations despite adverse currency moves, thanks to stronger non-interest income generation. This enabled the management to reiterate its RoTE guidance ..."

PDF page sample
Pages
60
Language
English
Published on
29/10/24
Download
You may also be interested by these reports :
25/09/26
We have downgraded our EPS projections over 2026-2028, accounting for a deteriorating global macro and ramping French macro risks in 2027-2028. The ...
24/09/26
The MPS CEO’s presentation at the BofA conference helped clarify the project. It is not a defensive project. Execution risk appears limited. The ...
23/09/26
Following the CMD, we have updated our projections to reflect both the new inputs provided by the management as well as the slightly downgraded macro ...
21/09/26
SocGen’s 2026 CMD “enhances” its turnaround: 3% revenue CAGR, absolute cost cut (€16.3bn cost target in 2029), C/I ratio below 55%, and 13-14% ROTE ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO